# Tatva Chintan Pharma Chem (NSE: TATVA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/TATVA · Pivot · prices to 21 Oct 2026

Tatva Chintan Pharma Chem (NSE: TATVA) closed at ₹1,925.00 on 21 Oct 2026. With a market capitalisation of ₹4,478 Cr, it ranks 839th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

At its last close the stock traded at 106.2× trailing earnings, against a return on equity of 5.4% in FY26. Over the past year the share price has risen 77.2%. Its 52-week range is ₹1,044.10 (30 Mar 2026) to ₹2,113.60 (21 Oct 2026); the last close is 8.9% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹167 Cr (+43.0% year on year) and net profit ₹16 Cr (+140.3%), on a consolidated basis. Promoters held 72.02% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,925.00 |
| Market cap | ₹4,478 Cr |
| P/E (trailing) | 106.2 |
| ROE | 5.4% (FY26) |
| ROCE | 7.6% (FY26) |
| Debt to equity | 0.15 |
| 52-week high | ₹2,113.60 (21 Oct 2026) |
| 52-week low | ₹1,044.10 (30 Mar 2026) |
| 1-year return | +77.2% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹167 Cr | +43.0% | ₹16 Cr | +140.3% | ₹6.83 |
| Q4 FY26 | ₹134 Cr | +24.4% | ₹10 Cr | +901.9% | ₹4.41 |
| Q3 FY26 | ₹131 Cr | +52.9% | ₹15 Cr | +10,735.7% | ₹6.49 |
| Q2 FY26 | ₹124 Cr | +47.9% | ₹10 Cr | — | ₹4.24 |
| Q1 FY26 | ₹117 Cr | +10.8% | ₹7 Cr | +27.6% | ₹2.84 |
| Q4 FY25 | ₹108 Cr | +9.8% | ₹1 Cr | −89.3% | ₹0.44 |
| Q3 FY25 | ₹86 Cr | +2.0% | ₹0 Cr | −96.0% | ₹0.06 |
| Q2 FY25 | ₹83 Cr | −13.6% | −₹1 Cr | −108.5% | −₹0.29 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹366 Cr | ₹0 Cr |
| FY24 | ₹379 Cr | ₹29 Cr |
| FY23 | ₹403 Cr | ₹40 Cr |
| FY22 | ₹428 Cr | ₹96 Cr |
| FY21 | ₹291 Cr | ₹51 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 72.02%
- Foreign institutions: 3.93%
- Domestic institutions: 3.11%
- Non-institutions: 20.94%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Laxmi Organic Industries](https://app.pivotnow.in/stock/LXCHEM) | ₹170.90 | ₹4,738 Cr | 59.8 | — |
| [Foseco India](https://app.pivotnow.in/stock/FOSECOIND) | ₹6,185.00 | ₹4,662 Cr | 50.9 | — |
| [Tanfac Ind](https://app.pivotnow.in/stock/TANFACIND) | — | ₹4,568 Cr | — | — |
| [Yasho Industries](https://app.pivotnow.in/stock/YASHO) | ₹3,519.70 | ₹4,242 Cr | 167.8 | — |
| [Gujarat Alkalies and Chemicals](https://app.pivotnow.in/stock/GUJALKALI) | ₹570.10 | ₹4,187 Cr | — | — |
| [Vishnu Chemicals](https://app.pivotnow.in/stock/VISHNU) | ₹614.90 | ₹4,139 Cr | 29.1 | — |

## Questions and answers

### What is the share price of Tatva Chintan Pharma Chem today?

Tatva Chintan Pharma Chem (NSE: TATVA) last closed at ₹1,925.00 on 21 Oct 2026. Its 52-week high is ₹2,113.60 and its 52-week low is ₹1,044.10.

### What is the market cap of Tatva Chintan Pharma Chem?

Tatva Chintan Pharma Chem's market capitalisation is ₹4,478 Cr (₹4,478 Cr) at the 19 Oct 2026 close, ranking 839th among the NSE companies Pivot tracks.

### What is the P/E ratio of Tatva Chintan Pharma Chem?

Tatva Chintan Pharma Chem trades at a trailing P/E of 106.2. The median P/E of the 4 closest Chemicals peers by market cap is 59.8.

### What is the ROE and ROCE of Tatva Chintan Pharma Chem?

Return on equity was 5.4% in FY26 and return on capital employed was 7.6% in FY26 (consolidated figures).

### Is Tatva Chintan Pharma Chem a debt-free company?

No. Tatva Chintan Pharma Chem's debt-to-equity ratio was 0.15 in FY26, with total debt of ₹5 Cr.

### What were Tatva Chintan Pharma Chem's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Tatva Chintan Pharma Chem reported revenue of ₹167 Cr, +43.0% year on year, and net profit of ₹16 Cr, +140.3% year on year.

### How has Tatva Chintan Pharma Chem stock performed over the last year?

Tatva Chintan Pharma Chem's share price has risen 77.2% over the past year, +11.7% over three months and +12.3% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Tatva Chintan Pharma Chem?

As of 30 Jun 2026: promoters 72.02%, foreign institutions 3.93%, domestic institutions 3.11%, non-institutions 20.94%.

### Who are Tatva Chintan Pharma Chem's competitors?

The listed Chemicals companies closest to Tatva Chintan Pharma Chem by market cap are Laxmi Organic Industries, Foseco India, Tanfac Ind, Yasho Industries, Gujarat Alkalies and Chemicals and Vishnu Chemicals.

### Is Tatva Chintan Pharma Chem a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Tatva Chintan Pharma Chem's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on TATVA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.